Icu Medical Inc. (ICUI) intrinsic value & 10-year financials
Icu Medical Inc. (ICUI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 21.8% a year to $2.2B, with an average return on invested capital of 5.0%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $162.99
- Market cap
- $4.1B
- Revenue (FY2025)
- $2.2B
- Revenue growth (10-yr CAGR)
- 21.8%
- ROIC (10-yr avg)
- 5.0%
- Free cash flow (FY2025)
- $91.8M
ICUI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.2B | $732.0K | $0.03 | $91.8M | 1.9% | 0.7% |
| FY2024 | $2.4B | -$117.7M | -$4.83 | $124.7M | 1.8% | 1.3% |
| FY2023 | $2.3B | -$29.7M | -$1.23 | $82.3M | 1.0% | 0.3% |
| FY2022 | $2.3B | -$74.3M | -$3.11 | -$152.4M | -1.9% | -1.2% |
| FY2021 | $1.3B | $103.1M | $4.74 | $199.0M | 9.4% | 9.2% |
| FY2020 | $1.3B | $86.9M | $4.02 | $130.7M | 7.7% | 7.6% |
| FY2019 | $1.3B | $101.0M | $4.69 | $4.6M | 8.5% | 8.3% |
| FY2018 | $1.4B | $28.8M | $1.33 | $67.5M | 1.5% | 1.8% |
| FY2017 | $1.3B | $68.6M | $3.29 | $79.9M | -1.2% | -7.0% |
| FY2016 | $379.4M | $63.1M | $3.66 | $66.6M | 21.9% | 28.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ICU MEDICAL INC/DE is a consistent compounder, expanding top-line revenue at 21.8% annually over the past decade.
ICU MEDICAL INC/DE has historically struggled to out-earn its cost of capital, averaging just 5.3% ROIC.
Over the decade, ICU MEDICAL INC/DE shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ICU MEDICAL INC/DE is modeled at -41.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1.92 per share.